Schreihofer AM, Guyenet PG
While the medication has demonstrated substantial weight loss in clinical trials, it is important to understand that tirzepatide is not specifically a "fat-burning" agent in the traditional sense, but rather works through appetite suppression and metabolic regulation
But lets take a closer look
If you take insulin or sulfonylureas alongside your GLP-1 medication, discuss with your healthcare team whether these doses need adjustment as your eating patterns change, to avoid low blood glucose levels that can worsen fatigue
Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation